<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(10)</volume><submitter>Jones G</submitter><pubmed_abstract>Shiga toxin-producing Escherichia coli-associated pediatric hemolytic uremic syndrome (STEC-HUS) remains an important public health risk in France. Cases are primarily sporadic, and geographic heterogeneity has been observed in crude incidence rates. We conducted a retrospective study of 1,255 sporadic pediatric STEC-HUS cases reported during 2012-2021 to describe spatiotemporal dynamics and geographic patterns of higher STEC-HUS risk. Annual case notifications ranged from 109 to 163. Most cases (n = 780 [62%]) were in children &lt;3 years of age. STEC serogroups O26, O80, and O157 accounted for 78% (559/717) of cases with serogroup data. We identified 13 significant space-time clusters and 3 major geographic zones of interest; areas of southeastern France were included in >5 annual space-tim</pubmed_abstract><journal>Emerging infectious diseases</journal><pagination>2054-2064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10521606</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sporadic Shiga Toxin-Producing Escherichia coli-Associated Pediatric Hemolytic Uremic Syndrome, France, 2012-2021.</pubmed_title><pmcid>PMC10521606</pmcid><pubmed_authors>Cointe A</pubmed_authors><pubmed_authors>Mariani-Kurkdjian P</pubmed_authors><pubmed_authors>Lefevre S</pubmed_authors><pubmed_authors>Le Strat Y</pubmed_authors><pubmed_authors>Bonacorsi S</pubmed_authors><pubmed_authors>Jones G</pubmed_authors><pubmed_authors>Weill FX</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sporadic Shiga Toxin-Producing Escherichia coli-Associated Pediatric Hemolytic Uremic Syndrome, France, 2012-2021.</name><description>Shiga toxin-producing Escherichia coli-associated pediatric hemolytic uremic syndrome (STEC-HUS) remains an important public health risk in France. Cases are primarily sporadic, and geographic heterogeneity has been observed in crude incidence rates. We conducted a retrospective study of 1,255 sporadic pediatric STEC-HUS cases reported during 2012-2021 to describe spatiotemporal dynamics and geographic patterns of higher STEC-HUS risk. Annual case notifications ranged from 109 to 163. Most cases (n = 780 [62%]) were in children &lt;3 years of age. STEC serogroups O26, O80, and O157 accounted for 78% (559/717) of cases with serogroup data. We identified 13 significant space-time clusters and 3 major geographic zones of interest; areas of southeastern France were included in >5 annual space-tim</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-29T01:57:53.252Z</modification><creation>2025-04-06T01:35:03.161Z</creation></dates><accession>S-EPMC10521606</accession><cross_references><pubmed>37735746</pubmed><doi>10.3201/eid2910.230382</doi></cross_references></HashMap>